FOGSI EEBR 2025: Ethical Evidence-Based Recommendations: Fibroids

Written in association with the Federation of Obstetric and Gynaecological Societies of India (FOGSI), and with contributions from a multitude of recognised experts led by FOGSI (2025-2026) president Sunita Tandulwadkar; the Ethical Evidence-based Recommendations (EEBR) series provides clinicians with the latest updates and advances in the field, with each book focusing on a different subspecialty.

Written in association with the Federation of Obstetric and Gynaecological Societies of India (FOGSI), and with contributions from a multitude of recognised experts led by FOGSI (2025-2026) president Sunita Tandulwadkar; the Ethical Evidence-based Recommendations (EEBR) series provides clinicians with the latest updates and advances in the field, with each book focusing on a different subspecialty.

Uterine fibroids are growths made of muscle and tissue that form in or on the wall of the uterus. They are usually benign and are the most common noncancerous tumour in females. Fibroids can cause a variety of symptoms including pain and heavy irregular bleeding. Some women have no symptoms and are unaware that they have the condition.

The EEBRs in this book begin with detail on the origins, aetiology, pathophysiology, and risk factors associated with fibroids, providing practitioners with a fundamental understanding of hormonal, genetic and environmental influences. The text examines clinical presentation and locations of fibroids, atypical fibroids, and degeneration patterns, helping clinicians recognise and manage the diversities of the condition effectively.  

Other titles in the series include:

• Antenatal Fetal Surveillance
• Endometriosis
• Genetics in Obstetrics and Gynecology
• Hyperglycemia in Pregnancy
• Hypertensive Disorders of Pregnancy
• Induction of Labor
• Polycystic Ovary Syndrome
• Postpartum Hemorrhage
• Preterm Labor